Skip Nav Destination
Issues
Editorials
The Biology Behind
Featured Articles
Clinical Trials
Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia
James L. Mulshine; Jane C. Atkinson; Robert O. Greer; Vassiliki A. Papadimitrakopoulou; Carter Van Waes; Susan Rudy; Jack W. Martin; Seth M. Steinberg; David J. Liewehr; Ingalill Avis; R. Ilona Linnoila; Stephen Hewitt; Scott M. Lippman; Robin Frye; Paul F. Cavanaugh, Jr.
Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125: Immunological Response and Survival (Phase Ib/II)
Silke Reinartz; Siegmund Köhler; Harald Schlebusch; Karl Krista; Patrick Giffels; Kirsten Renke; Jens Huober; Volker Möbus; Rolf Kreienberg; Andreas duBois; Paul Sabbatini; Uwe Wagner
Molecular Oncology, Markers, Clinical Correlates
Osteopontin But Not Osteonectin Messenger RNA Expression Is a Prognostic Marker in Curatively Resected Non-Small Cell Lung Cancer
Sylke Schneider; JiMin Yochim; Jan Brabender; Kazumi Uchida; Kathleen D. Danenberg; Ralf Metzger; Paul M. Schneider; Dennis Salonga; Arnulf H. Hölscher; Peter V. Danenberg
Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Ulrich Keilholz; Petra Goldin-Lang; Nikolaos E. Bechrakis; Nicole Max; Anne Letsch; Alexander Schmittel; Carmen Scheibenbogen; Karin Heufelder; Alexander Eggermont; Eckhard Thiel
Monitoring of Serum Her-2/neu Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer
Wolfgang J. Köstler; Barbara Schwab; Christian F. Singer; Rainer Neumann; Ernst Rücklinger; Thomas Brodowicz; Sandra Tomek; Monika Niedermayr; Michael Hejna; Günther G. Steger; Michael Krainer; Christoph Wiltschke; Christoph C. Zielinski
Experimental Therapeutics, Preclinical Pharmacology
Regular Articles
Clinical Trials
A Randomized Phase I and Pharmacological Trial of Sequences of 1,3-bis(2-Chloroethyl)-1-Nitrosourea and Temozolomide in Patients with Advanced Solid Neoplasms
Lisa A. Hammond; John R. Eckardt; John G. Kuhn; Stanton L. Gerson; Tom Johnson; Lon Smith; Ronald L. Drengler; Elizabeth Campbell; Geoffrey R. Weiss; Daniel D. Von Hoff; Eric K. Rowinsky
A Phase I and Pharmacokinetic Study of Irinotecan Given as a 7-Day Continuous Infusion in Metastatic Colorectal Cancer Patients Pretreated with 5-Fluorouracil or Raltitrexed
Gianluca Masi; Alfredo Falcone; Antonello Di Paolo; Giacomo Allegrini; Romano Danesi; Cecilia Barbara; Samanta Cupini; Mario Del Tacca
Cancer Biology, Immunology, Cytokines
Interleukin 1β Enhances Invasive Ability of Gastric Carcinoma through Nuclear Factor-κB Activation
Naoki Yamanaka; Takashi Morisaki; Hiroshi Nakashima; Akira Tasaki; Makoto Kubo; Hirotaka Kuga; Chihiro Nakahara; Katsuya Nakamura; Hirokazu Noshiro; Takashi Yao; Masazumi Tsuneyoshi; Masao Tanaka; Mitsuo Katano
Osteoblast-Derived Factors Induce Androgen-Independent Proliferation and Expression of Prostate-Specific Antigen in Human Prostate Cancer Cells
Natalie Blaszczyk; Bassam A. Masri; Nasrin R. Mawji; Takeshi Ueda; Gavan McAlinden; Clive P. Duncan; Nicholas Bruchovsky; Hans-Udo Schweikert; Doris Schnabel; Edward C. Jones; Marianne D. Sadar
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients
Gottfried E. Konecny; Y. Gloria Meng; Michael Untch; He-Jing Wang; Ingo Bauerfeind; Melinda Epstein; Petra Stieber; Jean-Michel Vernes; Johnny Gutierrez; Kyu Hong; Malgorzata Beryt; Hermann Hepp; Dennis J. Slamon; Mark D. Pegram
Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma of Patients with Nonnasopharyngeal Head and Neck Carcinomas
Kwok Hung Yu; Y. M. Dennis Lo; Gary M. Tse; K. C. Allen Chan; Amy B. W. Chan; Katherine C. K. Chow; Tony K. F. Ma; Alexander C. Vlantis; Sing Fai Leung; C. Andrew van Hasselt; Philip J. Johnson; Anthony T. C. Chan
Allelic Loss of a Common Microsatellite Marker MYCL1: A Useful Prognostic Factor of Poor Outcomes in Colorectal Cancer
Takeshi Kambara; Gerald B. Sharp; Takeshi Nagasaka; Masanori Takeda; Hiromi Sasamoto; Hitoshi Nakagawa; Hiroshi Isozaki; Donald G. MacPhee; Jeremy R. Jass; Noriaki Tanaka; Nagahide Matsubara
[11C]Methionine Positron Emission Tomography and Survival in Patients with Bone and Soft Tissue Sarcomas Treated by Carbon Ion Radiotherapy
Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Takashi Tomemori; Kenji Sagou; Mei Tian; Susumu Kandatsu; Tadashi Kamada; Hiroshi Tsuji; Tetsuya Suhara; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Predictive Value of Biological Markers for Hepatocellular Carcinoma Patients Treated with Orthotopic Liver Transplantation
Michelangelo Fiorentino; Annalisa Altimari; Matteo Ravaioli; Elisa Gruppioni; Elena Gabusi; Barbara Corti; Marco Vivarelli; Pierre-Paul Bringuier; Jean-Yves Scoazec; Walter Franco Grigioni; Antonia D’Errico-Grigioni
Experimental Therapeutics, Preclinical Pharmacology
Blockage of 2-Deoxy-d-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy
Hendrik Seeliger; Markus Guba; Gudrun E. Koehl; Axel Doenecke; Markus Steinbauer; Christiane J. Bruns; Christine Wagner; Erika Frank; Karl-Walter Jauch; Edward K. Geissler
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds